These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9407435)
1. Role of local and systemic angiotensin in diabetic renal disease. Anderson S Kidney Int Suppl; 1997 Dec; 63():S107-10. PubMed ID: 9407435 [TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin II in diabetic nephropathy. Kennefick TM; Anderson S Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212 [TBL] [Abstract][Full Text] [Related]
3. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat. Anderson S Miner Electrolyte Metab; 1998; 24(6):406-11. PubMed ID: 9930380 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism. Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826 [TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin system and diabetic nephropathy. Gurley SB; Coffman TM Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683 [TBL] [Abstract][Full Text] [Related]
6. Activation of a local renin angiotensin system in podocytes by glucose. Durvasula RV; Shankland SJ Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149 [TBL] [Abstract][Full Text] [Related]
7. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes]. Strawn WB Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy. Tamura J; Konno A; Hashimoto Y; Kon Y Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318 [TBL] [Abstract][Full Text] [Related]
9. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats. de Resende MM; Mill JG Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137 [TBL] [Abstract][Full Text] [Related]
10. Modulation and function of extrarenal angiotensin receptors. Wang DH; Elijovich F Cell Biochem Biophys; 1999; 31(1):1-17. PubMed ID: 10505665 [TBL] [Abstract][Full Text] [Related]
11. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Ibrahim HN; Rosenberg ME; Hostetter TH Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211 [TBL] [Abstract][Full Text] [Related]
12. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Steckelings UM; Rompe F; Kaschina E; Unger T Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870 [TBL] [Abstract][Full Text] [Related]
13. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats. Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768 [TBL] [Abstract][Full Text] [Related]
14. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat. van Dijk DJ; Boner G; Giler S; Erman A J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):193-8. PubMed ID: 11881122 [TBL] [Abstract][Full Text] [Related]
15. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats. Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II and its receptors in the diabetic kidney. Burns KD Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776 [TBL] [Abstract][Full Text] [Related]
17. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II). Jacobsen PK J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484 [TBL] [Abstract][Full Text] [Related]
18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
19. The emerging role of angiotensin-converting enzyme-2 in the kidney. Burns KD Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686 [TBL] [Abstract][Full Text] [Related]
20. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials. Fernandez-Juárez G; Barrio V; de Vinuesa SG; Goicoechea M; Praga M; Luño J J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]